Grant · EU
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
What is bought or funded
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Eligibility
"> General conditions 1. Admissibility Conditions, proposal page limit and layout Admissibility conditions are described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. Proposal page limits and layout are described in Part B of the Application Form available in the Submission System. 2. Eligible Countries Eligible countries are described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide . 3. Other Eligibility Conditions In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding. If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used). Subject to restrictions for the protection of …
Matched suppliers (matched automatically)
| Sanergy | Kenya | |
| Agri Phero Solutionz | India | |
| Agroindustrias Amazonicas | Peru | |
| Brevel | Israel | |
| Entobel | Vietnam | |
| GenScript ProBio / Genscript | China | |
| MGI (BGI Group) | China | |
| Magalarva | Indonesia | |
| Marine Biotechnology Products- Mauritius | Mauritius | |
| Meihua Biological 梅花生物 (SSE 600873) | China |